These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2944)

  • 1. Effects of various inhibitors of tyrosine hydroxylase and dopamine beta-hydroxylase on rat self-stimulation after reserpine treatment.
    Stinus L; Thierry AM; Cardo B
    Psychopharmacologia; 1976 Feb; 45(3):287-94. PubMed ID: 2944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of psychotropic drugs and the roles of the noradrenergic and dopaminergic systems in the lateral hypothalamic self-stimulation behavior].
    Hasegawa K; Sakai U
    Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):815-26. PubMed ID: 1035185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some catecholamine inhibitors do not cause accumulation of nuclear estrogen receptors in rat hypothalamus and anterior pituitary gland.
    Blaustein JD; Brown TJ; McElroy JF
    Neuroendocrinology; 1986; 43(2):143-9. PubMed ID: 2873523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of catecholamine depleting drugs and d-amphetamine on self-stimulation of the substantia nigra and locus coeruleus.
    Cooper BR; Konkol RJ; Breese GR
    J Pharmacol Exp Ther; 1978 Mar; 204(3):592-605. PubMed ID: 24729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Roles of noradrenergic and dopaminergic systems in the self-stimulation behavior of the substantia nigra].
    Hasegawa K
    Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):827-35. PubMed ID: 1035186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible role of dopamine-beta-hydroxylase in the regulation of norepinephrine biosynthesis in rat brain.
    Wise CD; Belluzzi JD; Stein L
    Pharmacol Biochem Behav; 1977 Dec; 7(6):549-53. PubMed ID: 201940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Methoxy-4-hydroxyphenylglycol sulphate (MOPEG-SO4) as an index of cerebral noradrenaline turnover following depletion of transmitter stores in the rat.
    Dolphin A; Jenner P; Marsden CD
    J Pharm Pharmacol; 1978 Sep; 30(9):580-2. PubMed ID: 29100
    [No Abstract]   [Full Text] [Related]  

  • 8. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH; Davis WM
    J Pharmacol Exp Ther; 1977 Jul; 202(1):182-91. PubMed ID: 17725
    [No Abstract]   [Full Text] [Related]  

  • 9. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
    Dolphin AC; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress-related effects of various inhibitors of catecholamine synthesis in the mouse.
    Thornburg JE; Moore KE
    Arch Int Pharmacodyn Ther; 1971 Nov; 194(1):158-67. PubMed ID: 4399378
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the effectiveness of deserpidine, reserpine, and alpha-methyltyrosine on brain biogenic amines.
    Fulton SC; Healy MD
    Fed Proc; 1976 Dec; 35(14):2558-62. PubMed ID: 11134
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of tyrosine hydroxylase but not dopamine-beta-hydroxylase facilitates the action of behaviourally ineffective doses of neuroleptics.
    Antelman SM; Szechtman H; Chin P; Fisher AE
    J Pharm Pharmacol; 1976 Jan; 28(1):66-8. PubMed ID: 6656
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological studies on the noradrenergic control of luteinizing hormone secretion in the domestic fowl.
    Buonomo FC; Scanes CG
    Gen Comp Endocrinol; 1983 Mar; 49(3):358-63. PubMed ID: 6132854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shock-induced locomotor excitation following acute and chronic amphetamine treatment.
    Kokkinidis L; Irwin J; Anisman H
    Neuropharmacology; 1979 Jan; 18(1):13-22. PubMed ID: 33347
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of tyrosine hydroxylase and dopamine-beta-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity.
    Hollister AS; Breese GR; Cooper BR
    Psychopharmacologia; 1974 Mar; 36(1):1-16. PubMed ID: 4151923
    [No Abstract]   [Full Text] [Related]  

  • 16. Reserpine and the monoaminergic regulation of adrenal dopamine beta-hydroxylase activity.
    Lima L; Sourkes TL
    Neuroscience; 1986; 17(1):235-45. PubMed ID: 2938024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of reserpine and a tyrosine hydroxylase inhibitor on the monoamine levels in different regions of the rat central nervous system.
    Andén NE
    Eur J Pharmacol; 1967 Jan; 1(1):1-5. PubMed ID: 6058896
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological action of FD-008, a new dopamine-beta-hydroxylase inhibitor. III. Effects on endogenous biogenic amine levels in rats.
    Ishii Y; Homma M; Yoshikawa A; Umezawa H
    Arzneimittelforschung; 1975 Mar; 25(3):383-5. PubMed ID: 1174036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biphasic effect of chlorpromazine on rat paradoxical sleep: a study of dose-related mechanisms.
    Kafi S; Gaillard JM
    Eur J Pharmacol; 1978 Jun; 49(3):251-7. PubMed ID: 26579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of brain monoamines in release of gonadotropin before proestrus in the cyclic rat.
    Terasawa E; Bridson WE; Davenport JW; Goy RW
    Neuroendocrinology; 1975; 18(4):345-58. PubMed ID: 1240617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.